Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL) Stefan James Professor of Cardiology Uppsala Clinical.

Slides:



Advertisements
Similar presentations
Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia ( TASTE trial) Ole Fröbert, MD, PhD - on behalf of the TASTE investigators Departement.
Advertisements

ARCTIC investigators COI D ISCLOSURE FOR D R. M ONTALESCOT : Research Grants to the Institution or Consulting/Lecture Fees from Abbott Vascular, Astra-Zeneca,
TOTAL Culprit lesion thrombus burden after manual aspiration thrombectomy or PCI alone in STEMI The OCT Substudy of the TOTAL (ThrOmbecTomy versus PCI.
on behalf of the TOTAL Investigators
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
‘SMASH IT!’ Mark Mason Interventional Cardiologist Harefield Hospital
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
G.SARDELLA Dip.di SCIENZE CARDIOVASCOLARI POLICLINICO UMBERTO I GENNARO SARDELLA, MD, FACC,FESC O.U. of Invasive Cardiology, Dept. of Cardiovascular Sciences.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
SWEDE HEART Prospective Registry based Randomized Clinical Trials (RRCT) – a new concept for clinical research Lessons from the TASTE trial Stefan James,
Academic Medical Center Amsterdam Interventional Cardiology JACC Intv Oct; 2 (10): Within the past 12 months, our institution has had a financial.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
ATTEMPT study: pooled-Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data CLINICAL TRIAL UPDATE III ESC.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
on behalf of the TOTAL Investigators
RESEARCH, REDUCE III, X-AMINE ST, COOL-MI Azfar Zaman Freeman Hospital, Newcastle.
Academic Medical Center Amsterdam Interventional Cardiology Koch TCT 2008 A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
For OMA distribution only. Trademarks may be registered and are the property of their respective owners. © 2013 Medtronic, Inc. All rights reserved. UC ML.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Thrombectomy: beneficial (if ever) only in highly selected patients Prof. Imad Sheiban University of Turin, Turin, Italy.
Trial Vignettes 1-3 Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Trust.
Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.
↓ 30 d mortality ↓ Distal embolization ↑ Myocardial Blush 3 ↑TIMI 3 Post De Luca et al. EHJ 2008;29:
Treatment of Thrombotic Lesions Ramesh Daggubati, MD FACC FSCAI Director of Interventional Cardiology East Carolina University Greenville, NC USA.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Rationale for TOTAL trial: randomized trial of routine aspiration ThrOmbecTomy with PCI vs. PCI ALone in patients with STEMI undergoing primary PCI Sanjit.
Total Occlusion Study of Canada (TOSCA-2) Trial
STEMI ST ELEVATION MYOCARDIAL INFARCTION
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Strategies for Thrombus and No Reflow Management in the Cath Lab
Heart Valve Thrombosis & Neuro-Outcomes
Recent Breakthroughs in Cardiovascular Outcomes Trials in T2DM
Revascularization in Patients With Left Ventricular Dysfunction:
Should We Preload STEMI Patients with Antiplatelet Therapy?
For the HORIZONS-AMI Investigators
Infused AMI: Intracoronary IIb/IIIa Infusion for STEMI
Kirk N Garratt MSc MD FSCAI
DES Should be Used as the Default Stent in ACS!
Uppsala Clinical Research Center
ARCTIC-INTERRUPTION 2-year- Versus 1year Duration of Dual-Antiplatelet Therapy After DES implantation The randomized ARCTIC-Interruption Study JP Collet.
Is There a Role for Aspiration in STEMI?
On behalf of J. Belardi, M. Leon, L. Mauri,
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
Valsartan in Acute Myocardial Infarction Trial Investigators
The ANTARCTIC investigators
ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
TUXEDO–India Trial design: Patients with type 2 diabetes mellitus (DM2) and coronary artery disease undergoing PCI were randomized to receive Taxus Element.
How and why this study may change my practice ?
Dean J. Kereiakes et al. JACC 2017;70:
The HORIZONS-AMI Trial
3-Year Clinical Outcomes From the RESOLUTE US Study
For the HORIZONS-AMI Investigators
For the HORIZONS-AMI Investigators
A Systematic Review and Meta-analysis of Randomized Trials of Manual Thrombectomy in ST elevation myocardial infarction Investigators: Ashraf Alazzoni,
American College of Cardiology Presented by Dr. Michel R. Le May
Mancini JG, et al. Am J Cardiol.
What oral antiplatelet therapy would you choose?
European Heart Journal Advance Access
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Presentation transcript:

Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL) Stefan James Professor of Cardiology Uppsala Clinical Research Centre Uppsala University Uppsala, Sweden

Potential conflicts of interest AstraZeneca Pharmaceuticals Institutional Research grants/ consultant/Honoraria The Medicines Company Research grant/ consultant/ Honoraria Jansen consultant/ Honoraria Bayer consultant/ Honoraria Thermo Fisher Consultant/ Honoraria Swedish Research Council Research grant Swedish Heart and Lung Foundation Research grant Strategic Research Council Research grant

Impact of Macroscopic Distal Emboli Proximal LCX filling defect at primary PCI site Distal thromboemboli Distal embolization occurred in 15% patients after primary PCI  ↓ ST resolution ↑ Infarct size ↑ Mortality What is the impact of macroscopic dital embolization. Distal embolization is related to reduced myocardial reperfusion, more extensive myocardial damage and a poor prognosis. Therefore, additional pharmacological interventions and mechanical devices should be studied to prevent and treat distal embolization. Henriques JPS et al. EHJ 2002;23:1112-7

Macroscopic embolic debris is retrieved in >75% of primary PCI cases How common is distal embolization: macroscopic embolic debris as you can see in these patients is retrieved in more that 75 % of primary PCI-cases. The concept of thrombus aspiration prior to primary PCI in STEMI is intuitive and “feels right”

No evidence of reduction in Infarct Size These are results from three trials assessing infarct size in thrombus aspiration vs. Controls. P=0.004 P=0.20 P=0.46 Rescue catheter Export catheter Export catheter Kaltoft A et al. Circ 2006;114:40-47 Sardella G et al. JACC 2009;53:309–15 Svilaas T et al. NEJM 2008;358;-557-67 5

INFUSE-AMI - Primary powered endpoint - Median [IQR] 17.0% [9.0, 22.8] Median [IQR] 17.3% [7.1, 25.5] P=0.51 N=452 All anterior MI Sx-hosp <4 hrs TIMI 0-2 Infarct size, %LV Aspiration N=229 No aspiration N=223 Stone GW et al. JAMA 2012;307:1817-26

TAPAS: 1,071 pts 30 days 4.0% vs. 2.1% P=0.07 Time (days) Mortality (%) Conventional PCI Thrombus-Aspiration 100 200 300 400 2 4 6 8 10 12 1 year 7.6% vs. 4.0% P=0.04 A large confirmatory trial is needed (small trials with unexpected large effect sizes, need to be replicated) Vlaar et al. Lancet 2008;371:1915-20

All-cause mortality 1,071 pts HR up to 1 year 0.94 (0.78 – 1.15), P=0.57 HR up to 30 days 0.94 (0.72 - 1.22), P=0.63 N Engl J Med. 2013 Oct 24;369(17):1587-97 N Engl J Med. 2014 Sep 18;371(12):1111-20

Reinfarction Stent thrombosis TASTE, N= 7.244 2.7 HR 1 year 0.97 (0.73 – 1.28), P=0.81 HR 1 year 0.84 (0.50 – 1.40), P=0.51 HR 30 days 0.61 (0.34 - 1.07), P=0.09 HR 30 days 0.47 (0.20 - 1.02), P=0.06 N Engl J Med. 2013 Oct 24;369(17):1587-97 N Engl J Med. 2014 Sep 18;371(12):1111-20

All-cause mortality at 1 year Results consistent across major subgroups. N Engl J Med. 2013 Oct 24;369(17):1587-97 N Engl J Med. 2014 Sep 18;371(12):1111-20

TOTAL, N=10.732 1er Endpoint: risk of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or NYHA class IV heart failure within 180 days Patients with STEMI were assigned to primary PCI with or without thrombectomy At 180 days: there was no significant between-group difference in the primary outcome of death or cardiovascular events. N Engl J Med; Volume 372(15):1389-1398, 2015

TOTAL, N=10.732 Patients in the thrombectomy group had a higher rate of stroke at 30 days. N Engl J Med; Volume 372(15):1389-1398, 2015

TOTAL, N=10.732

TASTE and TOTAL TASTE, N= 7.244 TOTAL, N=10.732 CV death, recurrent myocardial infarction, cardiogenic shock, or heart failure within 180 days

Johnson, Vizzi, Strange Baumbach Residual thrombus burden Johnson, Vizzi, Strange Baumbach EuroIntervention 2014;10:167-168

Bhindi et al European Heart Journal (2015) 36, 1892–1900 TOTAL OCT-substudy Culprit lesion thrombus burden after thrombus aspiration Pre-stent Post-stent Bhindi et al European Heart Journal (2015) 36, 1892–1900

Distal Embolization During Primary PCI DE occurred in 30/450 pts (6.7%) after primary PCI with thrombus aspiration, and in 26/433 pts (6.0%) after primary PCI w/o aspiration Timing of first embolization Present on initial angiogram After guidewire passage After aspiration or balloon After stent Fokkema M et al. Eur Heart J. 2009;30:908-15

Conclusions The concept of thrombus aspiration prior to primary PCI in STEMI is intuitive and “feels right” Data from two major RCT 18000 patients show that routine aspiration does not reduce infarct size, MI, stent thrombosis, heart failure or mortality Routine thrombus aspiration is not beneficial in any investigated subgroup Thrombus aspiration is associated with an increased risk of stroke Routine aspiration should not be performed